» Articles » PMID: 34818556

Single-cell Landscape of Peripheral Immune Responses to Fatal SFTS

Overview
Journal Cell Rep
Publisher Cell Press
Date 2021 Nov 24
PMID 34818556
Citations 29
Authors
Affiliations
Soon will be listed here.
Abstract

Severe fever with thrombocytopenia syndrome (SFTS) is an emerging infectious disease with high fatality. Poor prognosis of SFTS has been associated with dysregulated host immunity; however, the immune patterns associated with pathophysiology involving SFTS exacerbation remain unclear. Here, we show that the single-cell landscape of peripheral immune responses is reprogrammed in SFTS and characterized by monocyte shift to an intermediate type along with complement activation, perturbation of plasmablast composition, and highly exhausted T cells, all correlated with lethal consequences. We identify the overexpression of interferon (IFN)-stimulated genes across most immune cell types after SFTSV infection, which are simultaneously related to older age, high viremia, and a hyperinflammatory response. A retrospective clinical study reveals no efficiency of IFN-α in treating SFTS. These data collectively support the intermediate monocytes and IFN-I-inducible plasmablasts to be major targets for SFTS virus infection, and they indicate the pivotal role of the IFN-I response in exacerbating hyperinflammation and lethal SFTS.

Citing Articles

Viral sepsis - pathophysiology and disease manifestation.

G Gurtler L, Schramm W, Seitz R Infection. 2025; .

PMID: 39961996 DOI: 10.1007/s15010-025-02486-z.


Severe fever with thrombocytopenia syndrome complicated with aspergillus endocarditis and multiple organ infarctions after glucocorticoid treatment in an immunocompetent man: a case report.

Zhao Y, Wu X, Wang X, Li L BMC Infect Dis. 2025; 25(1):116.

PMID: 39856548 PMC: 11761758. DOI: 10.1186/s12879-025-10503-7.


Lactate dehydrogenase to albumin ratio (LAR) is a novel predictor of fatal outcome in patients with SFTS: an observational study.

Meng T, Ding W, Lv D, Wang C, Xu Y Front Public Health. 2025; 12:1459712.

PMID: 39741938 PMC: 11685223. DOI: 10.3389/fpubh.2024.1459712.


Two-transcript signature for differentiation and clinical outcomes in severe fever with thrombocytopenia syndrome (SFTS) patients: a double-blind, multicenter, validation study.

Xu N, Wen S, Yao Y, Guan Y, Zhao L, Yang L J Clin Microbiol. 2024; 63(1):e0128224.

PMID: 39688402 PMC: 11784442. DOI: 10.1128/jcm.01282-24.


Transcriptome Profiles Characteristics of the Peripheral Immune in Patients with Severe Fever with Thrombocytopenia Syndrome.

Zhang Y, Sun Q, Liu T, Chang C, Chen X, Duan Q J Inflamm Res. 2024; 17:8357-8374.

PMID: 39530000 PMC: 11552436. DOI: 10.2147/JIR.S485118.